We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Test Breakthrough Enables Earlier, Less Invasive Endometriosis Detection

By LabMedica International staff writers
Posted on 27 Jan 2026

Endometriosis is a common gynecologic disease that occurs when tissue similar to the lining of the uterus grows outside the uterus. Despite its prevalence and severity, diagnosis can take an average of eight to 10 years for adults and up to 14 years for adolescents. Laparoscopy remains the gold standard for diagnosis of endometriosis, but it is a surgical and therefore invasive approach. Researchers have now identified blood-based molecular biomarkers that may support earlier, noninvasive detection in adolescents and young adults. 

The diagnostic approach developed by researchers at Yale School of Medicine (YSM; New Haven, CT, USA) centers on molecular biomarkers in blood, specifically small RNA molecules called microRNAs. MicroRNAs are present in every tissue and as regulators of gene expression, with disease-associated changes reflected in their activity. Prior Yale-led work identified circulating microRNAs that can be used to detect endometriosis noninvasively in adults. The latest study extends this concept to younger patients by describing a new microRNA signature associated with earlier stages of disease.

Image: Newly discovered biomarkers can enable earlier treatment of endometriosis (Photo courtesy of Shutterstock)
Image: Newly discovered biomarkers can enable earlier treatment of endometriosis (Photo courtesy of Shutterstock)

The study evaluated 51 adolescents and young adults ages 13 to 26 with pelvic pain who were scheduled for gynecologic surgery between 2019 and 2024. Blood samples were collected before surgery, and the surgeries confirmed endometriosis in 31 patients. Comparing blood from those with and without confirmed disease identified differences in microRNA expression reported as unique to early-stage endometriosis.

In a larger trial of 100 patients with an average age in the mid-30s, the researchers showed that these biomarkers could accurately detect endometriosis using a noninvasive blood test. The researchers stated that validation in distinct cohorts is needed before a blood test could become commercially available. The findings were published in Reproductive Biology and Endocrinology on January 15, 2026.

“We need to diagnose the disease much earlier, because endometriosis often doesn’t start when a person is 25. We have hard data that it commonly starts in adolescence, shortly after the first period” said lead author Alla Vash-Margita, MD, associate professor of obstetrics, gynecology, and reproductive science at YSM.  “Through future trials, we can and will develop a clinical diagnostic test that can be used for early diagnosis of endometriosis, so people don’t have to undergo major surgery,” added Vash-Margita.

Related Links
Yale School of Medicine


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Automated MALDI-TOF MS System
EXS 3000

Latest Molecular Diagnostics News

Diagnostic Toolbox to Rapidly and Reliably Detect Lymphatic Disease
27 Jan 2026  |   Molecular Diagnostics

Next-Generation Sequencing Could Enhance Early Disease Detection in Newborns
27 Jan 2026  |   Molecular Diagnostics

Simple Blood Test Detects Cancer in Patients with Non-Specific Symptoms
27 Jan 2026  |   Molecular Diagnostics